Literature DB >> 4174353

Immunoglobulin metabolism in ataxia telangiectasia.

W Strober, R D Wochner, M H Barlow, D E McFarlin, T A Waldmann.   

Abstract

Immunoglobulin metabolism has been studied in five patients with ataxia telangiectasia and in control subjects. Serum IgG levels were normal, increased, or decreased, reflecting normal, increased, or decreased synthetic rates, respectively. Serum IgM concentration was normal in three cases and slightly elevated in two cases. IgM turnover studies in the three cases with normal serum IgM levels showed normal IgM synthetic and catabolic rates. None of the five patients with ataxia telangiectasia had detectable serum IgA, and the maximum IgA synthetic rates possible for these patients were 0.3-10% of the normal mean synthetic rate (24 +/- 15 mg/kg per day) of 12 control individuals. Three of the patients had normal IgA fractional catabolic rates: 22% of the intravascular pool per day vs. 25 +/- 4% in controls. In two patients, fractional catabolic rates 4 and 20 times normal were found. In these cases, metabolic turnover, in vitro precipitation, radioimmunoelectrophoresis, and (or) the C'la fixation and transfer test provided evidence for the presence of a circulating antibody directed against IgA causing immune elimination of the molecule. These studies suggest that therapy with exogenous IgA may not be possible in some patients with ataxia telangiectasia or in other subjects with dysgammaglobulinemia.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4174353      PMCID: PMC297351          DOI: 10.1172/JCI105881

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  [Ataxiatelangiectasis. (7 personal cases)].

Authors:  S THIEFFRY; M ARTHUIS; J AICARDI; G LYON
Journal:  Rev Neurol (Paris)       Date:  1961-11       Impact factor: 2.607

3.  Studies of the metabolism of I-131-labeled human transferrin.

Authors:  M AWAI; E B BROWN
Journal:  J Lab Clin Med       Date:  1963-03

4.  A practical method for plasma albumin turnover studies.

Authors:  J D PEARSON; N VEALL; H VETTER
Journal:  Strahlentherapie       Date:  1958

5.  Efficient trace-labelling of proteins with iodine.

Authors:  A S McFARLANE
Journal:  Nature       Date:  1958-07-05       Impact factor: 49.962

6.  Chromatography of serum proteins in normal and pathologic sera: the distribution of protein-bound carbohydrate and cholesterol, siderophilin, thyroxin-binding protein, B12-binding protein, alkaline and acid phosphatases, radio-iodinated albumin and myeloma proteins.

Authors:  J L FAHEY; P F McCOY; M GOULIAN
Journal:  J Clin Invest       Date:  1958-02       Impact factor: 14.808

7.  Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

8.  [The ataxia-telangiectasis syndrome (Louis-Bar syndrome) from the immunologic viewpoint].

Authors:  P Ammann; V Lòpez; R Bütler; E Rossi
Journal:  Helv Paediatr Acta       Date:  1965-06

9.  Lymphoid tissue abnormalities associated with ataxia-telangiectasia.

Authors:  R D Peterson; M D Cooper; R A Good
Journal:  Am J Med       Date:  1966-09       Impact factor: 4.965

10.  ANTIBODY TO GAMMA-GLOBULIN IN INFANTS AND CHILDREN EXPOSED TO ISOLOGOUS GAMMA-GLOBULIN.

Authors:  E R STIEHM; H H FUDENBERG
Journal:  Pediatrics       Date:  1965-02       Impact factor: 7.124

View more
  23 in total

1.  Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin.

Authors:  T A Waldmann; W D Terry
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

2.  Abnormalities in the distribution of serum immunoglobulin concentrations in juvenile rheumatoid arthritis.

Authors:  J T Cassidy; R E Petty; D B Sullivan
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

3.  Serum IgG, IgA and IgM concentration in 1,038 patients with various neurological disorders.

Authors:  O J Kolar; A T Ross; H Gilliam
Journal:  Z Neurol       Date:  1972

4.  Metabolic properties of human IgA subclasses.

Authors:  A Morell; F Skvaril; G Noseda; S Barandun
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

5.  Catabolism and synovial transport of rheumatoid factor.

Authors:  R Bluestone; A Cracchiolo; L S Goldberg; C M Pearson
Journal:  Ann Rheum Dis       Date:  1970-01       Impact factor: 19.103

6.  In vivo metabolism of a monoclonal IgG cryoglobulin.

Authors:  G N Abraham; C Waterhouse; J J Condemi
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

7.  Immunological investigations in two brothers with ataxia telangiectasia Louis-Bar.

Authors:  H Schulte-Wissermann; P Gutjahr; P Zebisch; M Reitz; E M Lemmel
Journal:  Eur J Pediatr       Date:  1976-05-04       Impact factor: 3.183

8.  Disorders of B cells and helper T cells in the pathogenesis of the immunoglobulin deficiency of patients with ataxia telangiectasia.

Authors:  T A Waldmann; S Broder; C K Goldman; K Frost; S J Korsmeyer; M A Medici
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

Review 9.  Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Progress in the elucidation of the underlying biochemical defect.

Authors:  P J McKinnon
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

10.  The metabolism of IgE in patients with immunodeficiency states and neoplastic conditions.

Authors:  A Iio; W Strober; S Broder; S H Polmar
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.